GR
Gregory R Friberg sold $303K of BMRN stock
Gregory R Friberg, EVP, Chief R&D Officer of Biomarin Pharmaceutical Inc (BMRN), sold 5,147 shares of BMRN stock worth $303K, per an SEC Form 4 filed Nov 19, 2026.
It was an open-market sale.
The trade happened on Nov 18, 2026, 1 day before it was made public.
BMRN has moved -0.0% since the trade date, from $61.43 to $61.42 (Nov 19, 2026 close).
- Traded
- Nov 18, 2026
- Disclosed
- Nov 19, 2026
- Filing delay
- 1 day
- Price since
- -0.0%
- Role
- EVP, Chief R&D Officer
- Source
- SEC Form 4